Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tricyclic Antidepressants for Autism Spectrum Disorders (ASD) in Children and Adolescents: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435811/all/Creatine_and_creatine_analogues_in_hypertension_and_cardiovascular_disease:_Cochrane_systematic_review. Accessed 19 March 2024.
Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435811/all/Creatine_and_creatine_analogues_in_hypertension_and_cardiovascular_disease:_Cochrane_systematic_review. Accessed March 19, 2024.
Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435811/all/Creatine_and_creatine_analogues_in_hypertension_and_cardiovascular_disease:_Cochrane_systematic_review
Tricyclic Antidepressants for Autism Spectrum Disorders (ASD) in Children and Adolescents: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435811/all/Creatine_and_creatine_analogues_in_hypertension_and_cardiovascular_disease:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents: Cochrane systematic review
ID - 435811
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435811/all/Creatine_and_creatine_analogues_in_hypertension_and_cardiovascular_disease:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -